Designing corticosteroid drugs for pulmonary selectivity.

Proceedings of the American Thoracic Society

Volumn 1, Issue 4, 2004, Pages 352-355

  Biggadike, Keith ^a   Uings, Iain ^a   Farrow, Stuart N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID;

ASTHMA; BIOAVAILABILITY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; ORAL DRUG ADMINISTRATION; REVIEW; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL AVAILABILITY; CLINICAL TRIALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LUNG; SENSITIVITY AND SPECIFICITY;

EID: 22944491409     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200409-048TA     Document Type: Review

References (42)